Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Managing Phosphorus in Chronic Kidney Disease (Slides With Transcript)
Link ID 8520
Title Managing Phosphorus in Chronic Kidney Disease (Slides With Transcript)
Url http://www.medscape.com/viewarticle/579532?src=rss
Description
Category Articles > Cardiology
Keywords
Date Sep 10, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. ACE Inhibitors or ARBs in Hypertension? In Chronic Kidney Disease?
  Two reviews have concluded that angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are similarly effective in the treatment of hypertension and proteinuria, respectively. Medscape Medical News
Category:   Articles > Cardiology


2. Any Degree of Albuminuria Signals Increased Cardiovascular Risk
  Albuminuria, even in low levels within the "normal" range, is an independent predictor of cardiovascular and all-cause mortality, a new analysis of the PEACE trial shows. Heartwire
Category:   Articles > Cardiology


3. Strategies for Blood Management in High-Risk Patients Undergoing Cardiothoracic Surgery
  Drs. Ferraris, Levy, and Hammon explore identifying patients who are at high risk of bleeding in cardiothoracic surgery and discuss multimodal interventions for reducing bleeding and blood transfusion. Medscape Cardiology
Category:   Articles > Cardiology


4. Diabetic Retinopathy Independently Predicts New Heart Failure
  The presence of diabetic retinopathy in patients without clinical heart disease could lead to subclinical left ventricular dysfunction, according to Atherosclerosis Risk in Communities investigators. Medscape Medical News
Category:   Articles > Cardiology


5. Aliskiren Reduces LVH to Same Extent as Losartan
  A combination of the new direct renin inhibitor aliskiren and losartan is no more effective than either drug alone in reducing left ventricular hypertrophy. Nevertheless, the results show that the two drugs are equivalent in this regard, providing the first solid data that aliskiren can reduce LV mass and adding to the body of knowledge about the new drug, says the lead investigator. Heartwire
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS